Subtypes of functional α1-adrenoceptor

Cellular and Molecular Life Sciences

Volumn 67, Issue 3, 2010, Pages 405-417

  Docherty, James R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

1A Adrenoceptors; 1B Adrenoceptors; 1D Adrenoceptors; A1 Adrenoceptors; Benign prostatic hypertrophy; Blood pressure; Smooth muscle contraction; Vascular smooth muscle

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5 METHYL 3 [3 [4 [2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 1H PYRIMIDINE 2,4 DIONE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; AH 11110A; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BENOXATHIAN; CYCLAZOSIN; INOSITOL PHOSPHATE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; PRAZOSIN; PSEUDOEPHEDRINE; RISPERIDONE; SILODOSIN; TAMSULOSIN; UNCLASSIFIED DRUG; WB 41001; ALPHA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

BLADDER NECK; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CELL MEMBRANE; HUMAN; HYPERTENSION; HYPOTENSION; NONHUMAN; PHENOTYPE; PROSTATE; PROTEIN FUNCTION; REVIEW; SMOOTH MUSCLE CONTRACTION; TEMPERATURE; THERMOREGULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; CLASSIFICATION; INVERSE AGONISM; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SECOND MESSENGER; SMOOTH MUSCLE;

MUS;

ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE REGULATION; DRUG INVERSE AGONISM; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; INOSITOL PHOSPHATES; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ADRENERGIC, ALPHA-1; SECOND MESSENGER SYSTEMS; VASOCONSTRICTION;

EID: 75849125163     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-0174-4     Document Type: Review

References (151)

1. Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586-600
2. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
3. Starke K, Langer SZ (1979) A note on the terminology for presynaptic receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 1-3
4. Morrow AL, Creese I (1986) Characterization of alpha1- adrenergic receptor subtypes in rat brain: a re-evaluation of [3H]WB4101 and [3H]prazosin binding. Mol Pharmacol 29:321-330
5. 2+ in smooth muscle. Nature 329:333-335
6. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK (1988) Molecular cloning and expression of the cDNA for the hamster alpha1-adrenergic receptor. Proc Natl Acad Sci USA 85:7159-7163
7. Lomasney JW, Cotecchia S, Lorenz W, Leung W-Y, Schwinn DA, Yang-Feng TL, Brownstein M, Lefkowitz RJ, Caron M (1991) Molecular cloning and expression of the cDNA for the alpha1A-adrenergic receptor. J Biol Chem 266:6365-6369
8. Schwinn DA, Lomasney JW, Lorenz W, Szklut PJ, Fremeau RT, Yang-Feng TL, Caron MG, Lefkowitz RJ, Cotecchia S (1990) Molecular cloning and expression of the cDNA for a novel alpha1-adrenergic receptor subtype. J Biol Chem 265:8183-8189
9. Perez DM, Piascik MT, Graham RM (1991) Solution-phase library screening for the identification of rare clones: isolation of an alpha1D-adrenergic receptor cDNA. Mol Pharmacol 40:876-883
10. Hieble JP, Bylund DB, Clarke DE, Eikenbur DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RR (1995) International Union of Pharmacology. X. Recommendation for nomenclature of alpha1-adrenoceptors: Consensus update. Pharmacol Rev 47:267-270
11. Docherty JR (1998) Subtypes of functional alphal- and alpha2- adrenoceptors. Eur J Pharmacol 361:1-15
12. Guimar ães S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319-356
13. Hodges AN, Lynn BM, Bula JE, Donaldson MG, Dagenais MO, McKenzie DC (2003) Effects of pseudoephedrine on maximal cycling power and submaximal cycling efficiency. Med Sci Sports Exerc 35:1316-1319
14. Swain RA, Harsha DM, Baenziger J, Saywell RM Jr (1997) Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion? Clin J Sport Med 7:168-173
15. Drew CD, Knight GT, Hughes DT, Bush M (1978) Comparison of the effects of D-(-)-ephedrine and L-(?)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br J Clin Pharmacol 6:221-225
16. Empey DW, Young GA, Letley E, John GC, Smith P, Mc- Donnell KA, Bagg LR, Hughes DT (1980) Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol 9:351-358
17. Bright TP, Sandage BW Jr, Fletcher HP (1981) Selected cardiac and metabolic responses to pseudoephedrine with exercise. J Clin Pharmacol 21:488-492
18. Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, Khan IA, Feller D (2007) Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)- adrenergic receptor subtypes. J Pharmacol Exp Ther 322:214
19. Vansal SS, Feller DR (1999) Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol 58:807-810
20. Ulahannan TJ, Karpe F, Humphreys SM, Matthews DR, Frayn KN (2002) Effects of acute administration of doxazosin on fasting and postprandial haemodynamics and lipid metabolism in healthy subjects. Horm Metab Res 34:499-503
21. Flechtner-Mors M, Jenkinson CP, Alt A, Biesalski HK, Adler G, Ditschuneit HH (2004) Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity. Obes Res 12:612-620
22. Chen Q, Takahashi S, Zhong S, Hosoda C, Zheng HY, Ogushi T, Fujimura T, Ohta N, Tanoue A, Tsujimoto G, Kitamura T (2005) Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol 174:370-374
23. Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A (2007) Alpha1- adrenoceptors are required for normal male sexual function. Br J Pharmacol 152:332-340
24. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89
25. Furuya S, Kumamoto Y, Yokoyama E, Tsukamoto T, Izumi T, Abiko Y (1982) Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 128:836-839
26. Caine M (1986) The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 136:1-4
27. Nickel JC, Sander S, Moon TD (2008) A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Int J Clin Pract 62:1547-1559
28. Kojima Y, Sasaki S, Shinoura H, Hayashi Y, Tsujimoto G, Kohri K (2006) Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients. Prostate 66:761-767
29. 1A-adrenoceptor antagonist, displays low affinity for functional alpha1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49:209-215
30. Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP (1999) In vitro alpha1-adrenoceptor pharmacology of Ro 70- 0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Br J Pharmacol 127:252-258
31. 1A receptor subtype. J Pharmacol Exp Ther 274:97-103
32. Sleight AJ, Koek W, Bigg DC (1993) Binding of antipsychotic drugs at alpha1A- and alpha1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors. Eur J Pharmacol 238:407-410
33. King HK, Goetz AS, Ward SDC, Saussy DL Jr (1994) AH11110A is selective for the α1B subtype of α1-adrenoceptors. Soc Neurosci Abstr 20 p 52
34. Marucci G, Angeli P, Buccioni M, Gulini U, Melchiorre C, Sagratini G, Testa R, Giardinà D (2005) (+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: functional evaluation in rat and rabbit tissues. Eur J Pharmacol 522:100-107
35. Eltze M (1996) In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha-1 adrenoceptor. Eur J Pharmacol 295:69-73
36. Stam WB, Van der Graaf PH, Saxena PR (1998) Functional characterisation of the pharmacological profile of the putative alpha1B-adrenoceptor antagonist, (?)-cyclazosin. Eur J Pharmacol 361:79-83
37. Eltze M, König H, Ullrich B, Grebe T (2001) Failure of AH11110A to functionally discriminate between alpha(1)- adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors. Eur J Pharmacol 415:265-276
38. 2-adrenoceptor subtypes. Mol Pharmacol 44:1165-1170
39. O'Rourke M, Kearns S, Docherty JR (1995) Investigations of the actions of chloroethylclonidine in rat aorta. Br J Pharmacol 115:1399-1406
40. O'Rourke M, Gavin K, Docherty JR (1997) Further investigation of the alpha-adrenoceptor-mediated actions of chloroethylclonidine in rat aorta. Eur J Pharmacol 336:37-42
41. Goetz AS, King HK, Ward SDC, True TA, Rimele TJ, Saussy DL (1995) BMY 7378 is a selective antagonist of the D subtype of alpha1-adrenoceptors. Eur J Pharmacol 272:R5-R6
42. Cleary L, Murad K, Bexis S, Docherty JR (2005) The alpha (1D)-adrenoceptor antagonist BMY 7378 is also an alpha (2C)-adrenoceptor antagonist. Auton Autacoid Pharmacol 25:135-141
43. Chaput Y, de Montigny C (1988) Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 246:359-370
44. Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, Muramatsu I (2000) Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature. J Urol 164:578-583
45. Aboud RW, Shafii M, Docherty JR (1993) Investigations of the subtypes of alpha1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br J Pharmacol 109:80-87
46. 1C-) adrenoceptor mediating contraction of rat epididymal vas deferens and an alpha1B-adrenoceptormediating contraction of the rat spleen. Br J Pharmacol 115:467-475
47. 2+ influx stimulated by diacylglycerol and PKC. Br J Pharmacol 123:317-325
48. Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C, Chapple CR (1997) The effects of tamsulosin, a high affinity antagonist at functional alpha1A- and alpha1D-adrenoceptor subtypes. Br J Pharmacol 120:231-238
49. Villalobos-Molina R, Lopez-Guerrero JJ, Ibarra M (1997) Alpha1D- and alpha1A-adrenoceptors mediate contraction in rat renal artery. Eur J Pharmacol 322:225-227
50. Villalobos-Molina R, Ibarra M (1996) Alpha1-adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the alpha1D or alpha 1A subtypes. Eur J Pharmacol 298:257-263
51. 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br J Pharmacol 120:819-826
52. 1B-adrenoceptors in phenylephrine induced positive inotropic response in isolated rat left atrium. J Cardiovasc Pharmacol 24:745-752
53. Fagura MS, Lyfdford SJ, Douggall IG (1997) Pharmacological classification of alpha1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br J Pharmacol 120:247-258
54. Mills K, Hausman N, Chess-Williams R (2008) Characterization of the alpha1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter. Br J Pharmacol 155:110-117
55. Furukawa K, Rosario DJ, Smith DJ, Chapple CR, Uchiyama T, Chess-Williams R (1995) Alpha1A-adrenoceptor-mediated contractile responses of the human vas deferens. Br J Pharmacol 116:1605-1610
56. Moriyama N, Nasu K, Takeuchi T, Akiyama K, Murata S, Mishimatsu H, Yano J, Tsujimoto G, Kawabe K (1997) Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br J Pharmacol 122:1009-1014
57. 1c-) adrenoceptor subtype. Br J Pharmacol 115:781-786
58. Teng C-M, Guh J-H, Ko F-N (1994) Functional identification of alpha1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. Eur J Pharmacol 265:61-66
59. Bexis S, Docherty JR (2009) Role of α1- and β3-adrenoceptor subtypes in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse. Br J Pharmacol 158:259-266
60. Bruchas MR, Toews ML, Bockman CS, Abel PW (2008) Characterization of the alpha1-adrenoceptor subtype activating extracellular signal-regulated kinase in submandibular gland acinar cells. Eur J Pharmacol 578:349-358
61. Ross SA, Rorabaugh BR, Chalothorn D, Yun J, Gonzalez-Cabrera PJ, McCune DF, Piascik MT, Perez DM (2003) The alpha(1B)- adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model. Cardiovasc Res 60:598-607
62. Gray K, Short J, Ventura S (2008) The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol 155:103-109
63. Woodcock EA (2007) Roles of alpha1A- and alpha1B-adrenoceptors in heart: insights from studies of genetically modified mice. Clin Exp Pharmacol Physiol 34:884-888
64. Flavahan NA, Vanhoutte PA (1986) Alpha1-adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol Sci 7:347-349
65. Docherty JR (1989) The pharmacology of alpha1- and alpha2- adrenoceptors: evidence for and against a further subdivision. Pharmacol Ther 44:241-284
66. Muramatsu I, Ohmura T, Kigoshi S, Hashimoto S, Oshita M (1990) Pharmacological subclassification of alpha1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197-201
67. Muramatsu I, Oshita M, Ohmura T, Kigoshi S, Akino H, Gobara M, Okada K (1995) Pharmacological characterization of alpha1- adrenoceptor subtypes in the human prostate: functional and binding studies. Br J Urol 74:572-578
68. Ford APDW, Berge NV, Clarke DE (1993) Characterisation of alpha1-adrenoceptors in isolated anococcygeus muscle of rat. Br J Pharmacol 109:112P
69. Ohmura T, Oshita M, Kigoshi S, Muramatsu I (1992) Identification of alpha1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br J Pharmacol 107:698-704
70. Amobi NI, Guillebaud J, Kaisary AV, Turner E, Smith IC (2002) Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens. Br J Pharmacol 136:127-135
71. Cleary L, Slattery J, Bexis S, Docherty JR (2004) Sympathectomy reveals alpha1A- and alpha1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br J Pharmacol 143:745-752
72. Smith KM, MacMillan JB, McGrath JC (1997) Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries. Br J Pharmacol 122: 825-832
73. Van der Graaf PH, Shankley NP, Black JW (1996) Analysis of the effects of alpha1-adrenoceptor antagonists on noradrenalinemediate contraction of rat small mesenteric artery. Br J Pharmacol 118:1308-1316
74. Recio P, Orensanz LM, Martínez MP, Navarro-Dorado J, Bustamante S, García-Sacristán A, Prieto D, Hernández M (2008) Noradrenergic vasoconstriction of pig prostatic small arteries. Naunyn Schmiedebergs Arch Pharmacol 376:397-406
75. Yamamoto Y, Koike K (1999) Alpha1-adrenoceptors in the guinea pig thoracic aorta. J Smooth Muscle Res 35:181-192
76. Nakamura S, Taniguchi T, Suzuki F, Akagi Y, Muramatsu I (1999) Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol 127:1367-1374
77. 1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br J Pharmacol 123:1359-1366
78. Fukasawa R, Taniguchi N, Moriyama N, Ukai Y, Yamazaki S, Ueki T, Kameyama S, Kimura K, Kawabe K (1998) The alpha1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate. Br J Urol 82:733-737
79. Gray KT, Ventura S (2006) Alpha1L-adrenoceptors mediate contractions of the isolated mouse prostate. Eur J Pharmacol 540:155-161
80. 1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 137-1135
81. Daniels DV, Gever JR, Jasper JR, Kava MS, Lesnick JD, Meloy TD, Stepan G, Williams TJ, Clarke DE, Chang DJ, Ford AP (1999) Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370:337-343
82. Morishima S, Suzuki F, Yoshiki H, Md Anisuzzaman AS, Sathi ZS, Tanaka T, Muramatsu I (2008) Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors. Br J Pharmacol 153:1485-1494
83. Martí D, Miquel R, Ziani K, Gisbert R, Ivorra MD, Anselmi E, Moreno L, Villagrasa V, Barettino D, D'Ocon P (2005) Correlation between mRNA levels and functional role of alpha1- adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. Am J Physiol Heart Circ Physiol 289:H1923-H1932
84. 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol 118:1403-1408
85. Ramsay D, Carr IC, Pediani J, Lopez-Gimenez JF, Thurlow R, Fidock M, Milligan G (2004) High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1Ladrenoceptor. Mol Pharmacol 66:228-239
86. Uberti MA, Hall RA, Minneman KP (2003) Subtype-specific dimerization of alpha1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379-1390
87. Eltze M (1996) Functional evidence for an alpha1B-adrenoceptor mediating contraction of the mouse spleen. Eur J Pharmacol 311:187-198
88. Cavalli A, Lattion A, Hummler E, Nenninger M, Pedrazzini T (1997) Decreased blood pressure response in mice deficient of the alpha 1b-adrenergic receptor. Proc Nat Acad Sci USA 94:11589-11595
89. Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G (2005) Two alpha1- adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 67:912-922
90. Daly CJ, Deighan C, McGee A, Mennie D, Ali Z, McBride M, McGrath JC (2002) A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse. Physiol Genomics 9:85-91
91. Daly CJ, Cotecchia S, McGrath JC (1998) Low frequency electrical field stimulation elicits responses in segments of mouse tail artery which are slower in alpha1B-knockout mice than in control mice. Naunyn Schmiedebergs Arch Pharmacol 358:R600
92. Zuscik MJ, Chalothorn D, Hellard D, Deighan C, McGee A, Daly CJ, Waugh DJ, Ross SA, Gaivin RJ, Morehead AJ, Thomas JD, Plow EF, McGrath JC, Piascik MT, Perez DM (2001) Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor. J Biol Chem 276:13738-13743
93. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL, Perez DM (1995) The specific contribution of the novel alpha- 1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275:1583-1589
94. Hussain M, Marshall I (1997) Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol 122:849-858
95. 1D-adrenoceptors in the rabbit ventricular myocardium: analysis with BMY 7378. Br J Pharmacol 122:1541-1550
96. Deighan C, Methven L, Naghadeh MM, Wokoma A, Macmillan J, Daly CJ, Tanoue A, Tsujimoto G, McGrath JC (2005) Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice. Br J Pharmacol 144:558-565
97. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G (2002) The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 109:765-775
98. Chalothorn D, McCune DF, Edelmann SE, Tobita K, Keller BB, Lasley RD, Perez DM, Tanoue A, Tsujimoto G, Post GR, Piascik MT (2003) Differential cardiovascular regulatory activities of the alpha1B- and alpha1D-adrenoceptor subtypes. J Pharmacol Exp Ther 305:1045-1053
99. Hosoda C, Tanoue A, Shibano M, Tanaka Y, Hiroyama M, Koshimizu TA, Cotecchia S, Kitamura T, Tsujimoto G, Koike K (2005) Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice. Br J Pharmacol 146:456-466
100. Zacharia J, Hillier C, Tanoue A, Tsujimoto G, Daly CJ, McGrath JC, MacDonald A (2005) Evidence for involvement of alpha1D-adrenoceptors in contraction of femoral resistance arteries using knockout mice. Br J Pharmacol 146:942-951
101. Filippi S, Parenti A, Donnini S, Granger HJ, Fazzini A, Ledda F (2001) Alpha(1D)-adrenoceptors cause endothelium-dependent vasodilatation in the rat mesenteric vascular bed. J Pharmacol Exp Ther 296:869-875
102. Vinci MC, Bellik L, Filippi S, Ledda F, Parenti A (2007) Trophic effects induced by alpha1D-adrenoceptors on endothelial cells are potentiated by hypoxia. Am J Physiol Heart Circ Physiol 293:H2140-H2147
103. Bexis S, Cleary L, McGrath JC, Tanoue A, Tsujimoto G, Docherty JR (2008) Alpha(1D)-adrenoceptors mediate nerve and agonist-evoked contractions in mouse vas deferens: evidence obtained from knockout technology. Auton Autacoid Pharmacol 28:81-85
104. Taki N, Tanaka T, Zhang L, Suzuki F, Israilova M, Taniguchi T, Hiraizumi-Hiraoka Y, Shinozuka K, Kunitomo M, Muramatsu I (2004) Alpha-1D adrenoceptors are involved in reserpineinduced supersensitivity of rat tail artery. Br J Pharmacol 142:647-656
105. Noguera MA, Ivorra MD, D'Ocon P (1996) Functional evidence of inverse agonism in vascular smooth muscle. Br J Pharmacol 119:158-164
106. Ziani K, Gisbert R, Noguera MA, Ivorra MD, D'Ocon P (2002) Modulatory role of a constitutively active population of alpha(1D)-adrenoceptors in conductance arteries. Am J Physiol Heart Circ Physiol 282:H475-H481
107. 2+ And phosphoinositide hydrolysis linked to constitutively active alpha1D-adrenoceptors in vascular smooth muscle. J Pharmacol Exp Ther 305:1006-1014
108. García-Cazarín ML, Smith JL, Olszewski KA, McCune DF, Simmerman LA, Hadley RW, Kraner SD, Michael T, Piascik MT (2008) The α1D-adrenergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells. J Mol Signal 3:6
109. McCune DF, Edelmann SE, Olges JR, Post GR, Waldrop BA, Waugh DJ, Perez DM, Piascik MT (2000) Regulation of the cellular localization and signaling properties of the alpha1B- and alpha1D-adrenoreceptors by agonists and inverse antagonists. Mol Pharmacol 57:659-666
110. Rossier O, Abuin L, Fanelli F, Leonardi A, Cotecchia S (1999) Inverse agonism and neutral antagonism at alpha1A- and alpha1B-adrenergic receptor subtypes. Mol Pharmacol 56: 858-866
111. Minneman KP (2007) Heterodimerization and surface localization of G protein coupled receptors. Biochem Pharmacol 73:1043-1050
112. Dalrymple MB, Pfleger KD, Eidne KA (2008) G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther 118:359-371
113. Uberti MA, Hague C, Oller H, Minneman KP, Hall RA (2005) Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 313:16-23
114. González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:9
115. Chen XL, Rembold CM (1995) Phenylephrine contracts rat tail artery by one electromechanical and three pharmacomechanical mechanisms. Am J Physiol 268:H74-H81
116. 2+. Pharmacol Rev 40:87-119
117. Wu D, Katz A, Lee C, Simon MI (1992) Activation of phospholipase C by alpha1-adrenergic receptors in mediated by the alpha subunits of Gq family. J Biol Chem 267: 25798-25802
118. 1D-adrenergic receptors to multiple signaling pathways is both G-protein and cell type specific. Mol Pharmacol 44:784-795
119. Exton JH (1994) Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1212:26-42
120. Gu H, Trajkovic S, LaBelle EF (1992) Norepinephrine-induced phosphatidylcholine hydrolysis by phospholipases D and C in rat tail artery. Am J Physiol 262:C1376-C1383
121. Ruan Y, Kan H, Parmentier J-H, Fatima S, Allen LF, Malik KU (1998) Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: inhibition by protein kinase A. J Pharmacol Exp Ther 284:575-585
122. + current via a cAMP/PKA-mediated pathway in the rat heart. Am J Physiol Cell Physiol 288:C577-C585
123. Mueed I, Bains P, Zhang L, MacLeod KM (2004) Differential participation of protein kinase C and Rho kinase in α1-adrenoceptor mediated contraction in rat arteries. Can J Physiol Pharmacol 82:895-902
124. + sensitivity of smooth muscle and non muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83:1325-1358
125. Piascik MT, Kusiak JW, Barron KW (1990) Alpha1-adrenoceptor subtypes and the regulation of peripheral hemodynamics in the conscious rat. Eur J Pharmacol 186:273-278
126. Castillo EF, López RM, Rodríguez-Silverio J, Bobadilla RA, Castillo C (1998) Alpha 1D-adrenoceptors contribute to the neurogenic vasopressor response in pithed rats. Fundam Clin Pharmacol 12:584-589 (Pubitemid 29535480)
127. López-Guerrero JJ, Ibarra M, Villalobos-Molina R (2005) Postjunctional alpha1-adrenoceptors in the vasculature of the pithed mouse are of the alpha1A-subtype. Auton Autacoid Pharmacol 25:101-103
128. Rokosh DG, Simpson PC (2002) Knockout of the alpha 1A/Cadrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99:9474-9479
129. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL, Cotecchia S, Rokosh DG, Grossman W, Foster E, Simpson PC (2003) The alpha(1A/C)- and alpha(1B)- adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 111:1783-1791
130. Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086-5094
131. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
132. Bexis S, Docherty JR (2008) Role of alpha(1)-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse. Br J Pharmacol 153:591-597
133. Sprague JE, Brutcher RE, Mills EM, Caden D, Rusyniak DE (2004) Attenuation of 3, 4-methylenedioxymethamphatamine (MDMA, Ecstasy)-induced rhabdomyolysis with α1- plus β3-adrenoceptor antagonists. Br J Pharmacol 142:667-670
134. Brahmadevara N, Shaw AM, MacDonald A (2004) Alpha1- adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta. Br J Pharmacol 142:781-787
135. Papay R,Gaivin R, Jha A, McCune DF,McGrath JC, RodrigoMC, Simpson PC, Doze VA, Perez DM (2006) Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J Comp Neurol 497:209-222
136. Papay R, Gaivin R, McCune DF, Rorabaugh BR, Macklin WB, McGrath JC, Perez DM (2004) Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. J Comp Neurol 478:1-10
137. Zuscik MJ, Sands S, Ross SA, Waugh DJ, Gaivin RJ, Morilak D, Perez DM (2000) Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 6:1388-1394
138. Chen Q, Li DP, Pan HL (2006) Presynaptic alpha1 adrenergic receptors differentially regulate synaptic glutamate and GABA release to hypothalamic presympathetic neurons. J Pharmacol Exp Ther 316:733-742
139. 2-adrenoceptors in rat isolated kidney. J Cardiovasc Pharmacol 9:500-507
140. Shinozuka K, Kunitomo M, Bjur RA, Westfall DP, Hattori K (1995) Effect of methoxamine on noradrenaline release in the caudal artery of hypertensive rats. Clin Exp Pharmacol Physiol 22:S88-S90
141. Bognar TI, Baretti R, Fischer S, Veldet C, Fuder H (1990) Alpha-adrenoceptor mediated facilitation of acetylcholine release in rat perfused heart. J Pharmacol Exp Ther 254:702-710
142. Keast JR, Kawatani M, De Groat WC (1990) Sympathetic modulation of cholinergic transmission in cat vesical ganglia is mediated by alpha1- and alpha2-adrenoceptors. Am J Physiol 258:R44-R50
143. Yoshimura N, de Groat WC (1992) Patch clamp analysis of afferent and efferent neurons that innervate the urinary bladder of the rat. Soc Neurosci Abstr 18:126
144. Somogyi GT, Tanowitz M, de Groat WC (1995) Prejunctional facilitatory alpha-1 adrenoceptors in the rat urinary bladder. Br J Pharmacol 114:1710-1716
145. Wada T, Hasegawa Y, Ono H (1997) Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity. Eur J Pharmacol 340:45-52
146. Sladek CD, Song Z (2008) Regulation of vasopressin release by co-released neurotransmitters: mechanisms of purinergic and adrenergic synergism. Prog Brain Res 170:93-107
147. Yuan WX, Chen SR, Chen H, Pan HL (2009) Stimulation of alpha(1)-adrenoceptors reduces glutamatergic synaptic input from primary afferents through GABA(A) receptors and T-type Ca(2?) channels. Neuroscience 158:1616-1624
148. Herold S, Hecker C, Deitmer JW, Brockhaus J (2005) Alpha1- adrenergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices. J Neurosci Res 82:571-579
149. Araneda RC, Firestein S (2006) Adrenergic enhancement of inhibitory transmission in the accessory olfactory bulb. J Neurosci 26:3292-3298
150. Li Y, van den Pol AN (2005) Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 25:173-183
151. Somogyi GT, Tanowitz M, Zernova G, de Groat WC (1996) M1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C. J Physiol 496:245-254